top of page
News, Events and Updates
Search
Anavex Raises $1.575 million
Jul 11, 2011
Anavex Rapidly Advances ANAVEX 2-73 for Alzheimer’s Disease, Phase I Clinical Trial Progressing Well
Jul 6, 2011
Anavex Advances Second Lead Compound; Initiates Scale-Up Manufacturing of ANAVEX 1-41
Jun 8, 2011
ANAVEX 2-73 Advances Phase I Clinical Trial for Alzheimer’s Disease
May 23, 2011
Anavex Comments on New Alzheimer’s Disease Diagnostic Guidelines
May 17, 2011
Anavex Appoints Robert Chisholm to Board of Directors
May 13, 2011
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
May 11, 2011
Anavex First-in-Human Dosing Commenced in ANAVEX 2-73 Clinical Trial for Alzheimer's Disease
Apr 20, 2011
Anavex Appoints Dr. Christopher Shackleton as an Advisor
Apr 8, 2011
Anavex to Hold Annual Meeting on April 11, 2011
Apr 6, 2011
Anavex Screening Healthy Volunteers for Phase I, First-in-Human Clinical Study in AD
Mar 31, 2011
43
44
45
46
47
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
